Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus–Infected Adults in the United States

Bing, Eric G.; Burnam, M. Audrey; Longshore, Douglas; Fleishman, John A.; Sherbourne, Cathy D.; London, Andrew S.; Turner, Barbara J.; Eggan, Ferd; Beckman, Robin L.; Vitiello, Benedetto; Morton, Sally C.; Orlando, Maria; Bozzette, Samuel A.; Ortiz-Barron, Lucila; Shapiro, Martin F.

doi:10.1001/archpsyc.58.8.721

Cited by 1,137 publications

(1,007 citation statements)

References 38 publications

Supporting

Mentioning

921

Contrasting

Unclassified

Order By: Relevance

“…Thus, findings from the reviewed studies are not generalizable to HIV-infected patients reporting mental health difficulties (the very patients who may benefit most from these interventions). Because rates of mental health concerns are often reported to be high among HIV-infected samples [69], future stress management programs should be adapted for individuals experiencing psychological distress. The role of premorbid mental health functioning could then be examined as a potential mechanism influencing the intervention's efficacy.…”

Section: Sample Characteristicsmentioning

confidence: 99%

Cognitive–Behavioral Stress Management Interventions for Persons Living with HIV: A Review and Critique of the Literature

2008

View full text Add to dashboard Cite

show abstract

Section: Sample Characteristicsmentioning

confidence: 99%

Cognitive–Behavioral Stress Management Interventions for Persons Living with HIV: A Review and Critique of the Literature

2008

View full text Add to dashboard Cite

show abstract

“…Numerous studies have documented negative reactions to HIV status disclosure (Alonzo & Reynolds, 1995;Black & Miles, 2002) and the subsequent detrimental consequences for psychological well-being (Bing et al, 2001;Heckman et al, 2004;Pence, Miller, Whetten, Eron, & Gaynes, 2006;Stutterheim et al, 2009) and social relationships (Lee & Craft, 2002), thus suggesting that it would be wise to keep one's HIV status a secret. Others have shown that concealing a stigmatized condition also has very substantial psychological and social costs, including stress (Greenberg & Stone, 1992;Pennebaker, Colder, & Sharp, 1990), poor mental health outcomes (Derlega, Winstead, Oldfield, & Barbee, 2003;Steward et al, 2008;Ullrich, Lutgendorf, & Stapleton, 2003), strained social interactions (Smart & Wegner, 1999), social isolation (Corrigan & Matthews, 2003;Remennick, 2000), and the insufficient provision of social support (Alonzo & Reynolds, 1995;Chesney & Smith, 1999).…”

mentioning

confidence: 99%

Psychological and Social Correlates of HIV Status Disclosure: The Significance of Stigma Visibility

Stutterheim¹,

Bos²,

Pryor³

et al. 2011

AIDS Education and Prevention

107

View full text Add to dashboard Cite

HIV-related stigma, psychological distress, self-esteem, and social support were investigated in a sample comprising people who have concealed their HIV status to all but a selected few (limited disclosers), people who could conceal but chose to be open (full disclosers), and people who had visible symptoms that made concealing difficult (visibly stigmatized). The visibly stigmatized and full disclosers reported significantly more stigma experiences than limited disclosers, but only the visibly stigmatized reported more psychological distress, lower self-esteem, and less social support than limited disclosers. This suggests that having a visible stigma is more detrimental than having a concealable stigma. Differences in psychological distress and self-esteem between the visibly stigmatized and full disclosers were mediated by social support while differences between the visibly stigmatized and limited disclosers were mediated by both social support and stigma. These findings suggest that social support buffers psychological distress in people with HIV.

show abstract

“…13 In a nationally representative survey of PLWH, 18 % of patients reported heavy drinking, 40 % reported illicit drug use other than marijuana, and 12 % screened positive for drug dependence. 15 Thus, it is critical for HIV care providers to screen for substance use in order to counsel patients and direct them toward treatment. In addition, providers may need to know about concurrent substance use with ART to avoid drug interactions.…”

Section: Introductionmentioning

confidence: 99%

Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

et al. 2016

View full text Add to dashboard Cite

BACKGROUND: Substance use is associated with higher rates of antiretroviral non-adherence and poor HIV outcomes. This study examined how HIV care providers assess substance use, and which questions elicit accurate patient disclosures. METHODS: We conducted a conversation analysis of audio-recorded encounters between 56 providers and 162 patients living with HIV (PLWH) reporting active substance use in post-encounter interviews (cocaine or heroin use in the past 30 days, > 4 days intoxicated in past 30 days, or AUDIT score ≥ 8). We assessed the frequency of substance use discussion, characterized the types of questions used by providers, and determined the frequency of accurate patient disclosure by question type. RESULTS: In 55 reports of active substance use, providers already knew about the use (n = 16) or patients disclosed unpromptednn = 39). Among the remaining 155 instances of substance use in which providers had the opportunity to elicit disclosure, 78 reports (50 %) of substance use were not discussed. Of the remaining 77 reports in which the provider asked about substance use, 55 (71 %) patients disclosed and 22 (29 %) did not disclose. Questions were classified as: open-ended (n = 18, BHow's the drinking going?^); normalizing (n = 14, BWhen was the last time you used?^); closed-ended (n = 36, BHave you used any cocaine?^); leading towards non-use (n = 9, BHave you been clean?^). Accurate disclosure followed 100 % of open-ended and normalizing questions, 58 % of closed-ended questions, and 22 % of leading questions. After adjusting for drug type, closed-ended questions were 41 % less likely (p < 0.001), and 'leading' questions 78 % less likely (p = 0.016) than broad and normalizing questions to elicit disclosures. CONCLUSION: Providers in this sample missed almost half of the opportunities to identify and discuss substance use with PLWH. Providers can increase the probability of patient disclosure by using open-ended or normalizing questions that ask about the Blast time^that the patient used drugs or alcohol.

show abstract

Psychiatric Disorders and Drug Use Among Human Immunodeficiency Virus–Infected Adults in the United States

Abstract: Many people infected with HIV may also have psychiatric and/or drug dependence disorders. Clinicians may need to actively identify those at risk and work with policymakers to ensure the availability of appropriate care for these treatable disorders.

Cited by 1,137 publications

References 38 publications

Cognitive–Behavioral Stress Management Interventions for Persons Living with HIV: A Review and Critique of the Literature

Cognitive–Behavioral Stress Management Interventions for Persons Living with HIV: A Review and Critique of the Literature

Psychological and Social Correlates of HIV Status Disclosure: The Significance of Stigma Visibility

Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

Contact Info

Product

Resources

About